Healthcare >> CEO Interviews >> October 17, 2011
Michael Fonstein, Ph.D., has served as CEO, President and Director of Cleveland BioLabs, Inc., since the company's inception in June 2003. Prior to this he served as Director of the DNA Sequencing Center at The University of Chicago from its creation in 1994 to 1998, when he left to found Integrated Genomics Inc., located in Chicago. He served as CEO and President of Integrated Genomics from 1997 to 2003. Dr. Fonstein has won several business awards, including the Incubator of the Year Award from the Association of University Related Research Parks. He was also the winner of a coveted KPMG Illinois High Tech Award. Profile
TWST: Would you begin with a brief historical sketch of the company and an overview of your current operations?
Dr. Fonstein: Cleveland BioLabs (CBLI) is a spinoff of the Cleveland Clinic. The company
